TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
25 mars 2024 08h02 HE
|
TeleDaas PLLC
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
Transfection Technologies Market to Reach $1.8 Billion by 2028, Driven by Advances and Growing Demand for Therapeutic Delivery
22 mars 2024 05h05 HE
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Global Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection,...
Precision Medicine Market Deal Making Trends: "Precision Medicine Collaboration and Licensing Deals (2016-2023)" Comprehensive Report Released
18 mars 2024 05h39 HE
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The realm of precision...
Bayer and Aignostics to collaborate on next generation precision oncology
14 mars 2024 03h30 HE
|
Aignostics GmbH
Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...
Global gRNA Research Analysis Report 2024: Precision in Gene Editing and Rising Adoption of NGS Technologies Enhancing gRNA Applications
13 mars 2024 11h55 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type...
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023
07 mars 2024 14h59 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Precision...
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
07 mars 2024 12h07 HE
|
SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief...
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
06 mars 2024 09h15 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
Global Generative AI in Personalized Medicine Market: Projected to Surge at a CAGR of 25.62% Through 2028 - Pharmaceuticals Dominate as AI Accelerates Drug Discovery
28 févr. 2024 12h15 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Generative AI in Personalized Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
27 févr. 2024 16h01 HE
|
Kura Oncology, Inc.
– Positive preliminary combination data from KOMET-007 trial of ziftomenib in NPM1-m and KMT2A-r AML, including effective mitigation of differentiation syndrome – – First patient dosed in KOMET-008...